Valbenazine
RxNorm 1918219
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1918219 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: valbenazine.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
FNPrescribable
Full form of descriptor (FN):
Product containing valbenazine (medicinal product)
(Atom ID: 10319524)
INPrescribable
Ingredient (IN):
Valbenazine
(Atom ID: 9160007)
PTPrescribable
Designated preferred name (PT):
Valbenazine
(Atom ID: 9265313)
FNPrescribable
Full form of descriptor (FN):
Valbenazine (substance)
(Atom ID: 9265314)
PTPrescribable
Designated preferred name (PT):
Valbenazine-containing product
(Atom ID: 10822501)
Patient Education
Valbenazine
Valbenazine is used to treat tardive dyskinesia (uncontrollable movement of the face, tongue, or other body parts). Valbenazine is in a class of medications called vesicular monoamine transporter 2 (VMAT2) inhibitors. It works by changing the activity of certain natural substances in the brain.
[Learn More]
* Please review the disclaimer below.